TWO SIGMA INVESTMENTS, LP - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 67 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q4 2020. The put-call ratio across all filers is 0.66 and the average weighting 1.4%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q1 2022$118,000
-71.2%
27,544
-68.8%
0.00%
-100.0%
Q4 2021$410,000
-12.2%
88,176
-24.7%
0.00%0.0%
Q3 2021$467,000
-18.4%
117,094
-12.3%
0.00%0.0%
Q2 2021$572,000
-45.9%
133,572
-46.4%
0.00%
-66.7%
Q1 2021$1,057,000
+22.1%
249,281
+11.7%
0.00%
+50.0%
Q4 2020$866,000
+14.6%
223,078
+18.9%
0.00%
-33.3%
Q3 2020$756,000
-36.1%
187,676
-32.5%
0.00%
-50.0%
Q2 2020$1,184,000
+286.9%
277,859
+281.7%
0.01%
+200.0%
Q1 2020$306,00072,7910.00%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q4 2020
NameSharesValueWeighting ↓
TANG KEVIN C 240,000$1,027,00095.09%
TANG CAPITAL MANAGEMENT LLC 10,049,224$43,011,0008.56%
RTW INVESTMENTS, LP 2,327,903$9,963,0000.15%
Boxer Capital, LLC 890,700$3,812,0000.13%
Tibra Equities Europe Ltd 72,600$311,0000.10%
WealthTrust Axiom LLC 25,400$108,0000.04%
GSA CAPITAL PARTNERS LLP 52,749$226,0000.02%
FIRST MIDWEST BANK TRUST DIVISION 34,231$147,0000.02%
HOLLENCREST CAPITAL MANAGEMENT 42,355$181,0000.02%
Summit Global Investments 48,500$208,0000.01%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders